Decreased levels of neuropeptide Y5 receptor binding sites in two experimental models of epilepsy

Neuroscience

Volumn 98, Issue 4, 2000, Pages 697-703

  Bregola, G ^a,b   Dumont, Y ^a   Fournier, A ^c   Zucchini, S ^b   Quirion, R ^a   Simonato, M ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF FERRARA   (Italy)

^c INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE   (Canada)

Author keywords

Epilepsy; Kainic acid; Kindling; Neuropeptide Y; Receptor autoradiography

Indexed keywords

IODINE 125; KAINIC ACID; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y5 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EPILEPSY; HIPPOCAMPUS; KINDLING; MALE; NEOCORTEX; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALS; CEREBRAL CORTEX; EPILEPSY; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; KAINIC ACID; KINDLING, NEUROLOGIC; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y;

EID: 0034049749     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00162-7     Document Type: Article

References (49)

1. Allen Y.S., Adrian T.E., Allen J.M., Tatemoto K., Crow T.J., Bloom S.R., Polak J.M. Neuropeptide Y distribution in the rat brain. Science. 221:1983;877-879.
2. Baraban S.C., Hollopeter G., Erickson J.C., Schwartzkroin P.A., Palmiter R.D. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci. 17:1997;8927-8936.
3. Bard J.A., Walker M.W., Branchek T.A., Weinshank R.L. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J. biol. Chem. 270:1995;26,762-26,765.
4. Bijak M. Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes. Neurosci. Lett. 268:1999;115-118.
5. Bleakman D., Harrison N.L., Colmers W.F., Miller R.J. Investigations into neuropeptide Y-mediated presynaptic inhibition in cultured hippocampal neurones of the rat. Br. J. Pharmacol. 107:1992;334-340.
6. Blomqvist A.G., Herzog H. Y-receptor subtypes - how many more? Trends Neurosci. 20:1997;294-298.
7. Chronwall B.M., DiMaggio D.A., Massari V.J., Pickel V.M., Ruggiero D.A., Tl O.D. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience. 15:1985;1159-1181.
8. Colmers W.F., Klapstein G.J., Fournier A., St-Pierre S., Treherne K.A. Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. Br. J. Pharmacol. 102:1991;41-44.
9. Colmers W.F., Lukowiak K., Pittman Q.J. Neuropeptide Y action in the rat hippocampal slice: site and mechanism of presynaptic inhibition. J. Neurosci. 8:1988;3827-3837.
10. Dumont Y., Fournier A., Quirion R. Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain. J. Neurosci. 18:1998;5565-5574.
11. 125I]peptide YY3-36 as selective Y1 and Y2 radioligands. J. Pharmacol. exp. Ther. 272:1995;673-680.
12. Dumont Y., Jacques D., Bouchard P., Quirion R. Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primate brains. J. comp. Neurol. 402:1998;372-384.
13. Dumont Y., Martel J.C., Fournier A., St-Pierre S., Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog. Neurobiol. 38:1992;125-167.
14. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381:1996;415-421.
15. Eva C., Keinanen K., Monyer H., Seeburg P., Sprengel R. Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Lett. 271:1990;81-84.
16. Forest M., Martel J.C., St-Pierre S., Quirion R., Fournier A. Structural study of the N-terminal segment of neuropeptide tyrosine. J. med. Chem. 33:1990;1615-1619.
17. Gariboldi M., Conti M., Cavaleri D., Samanin R., Vezzani A. Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors. Eur. J. Neurosci. 10:1998;757-759.
18. Gerald C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., Smith K.E., Vaysse P., Durkin M.M., Laz T.M., Linemeyer D.L., Schaffhauser A.O., Whitebread S., Hofbauer K.G., Taber R.I., Branchek T.A., Weinshank R.L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382:1996;168-171.
19. Gerald C., Walker M.W., Vaysse P.J., He C., Branchek T.A., Weinshank R.L. Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J. biol. Chem. 270:1995;26,758-26,761.
20. Gobbi M., Gariboldi M., Piwko C., Hoyer D., Sperk G., Vezzani A. Distinct changes in peptide YY binding to, and mRNA levels of, Y1 and Y2 receptors in the rat hippocampus associated with kindling epileptogenesis. J. Neurochem. 70:1998;1615-1622.
21. Greber S., Schwarzer C., Sperk G. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol. 113:1994;737-740.
22. Herzog H., Hort Y.J., Ball H.J., Hayes G., Shine J., Selbie L.A. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc. natn. Acad. Sci. U.S.A. 89:1992;5794-5798.
23. Ho M.W.Y., Beck-Sickinger A.G., Colmers W.F. Neuropeptide Y5 receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices. J. Neurophysiol. 83:2000;723-734.
24. Husum H., Mikkelsen J.D., Mork A. Extracellular levels of neuropeptide Y are markedly increased in the dorsal hippocampus of freely moving rats during kainic acid-induced seizures. Brain Res. 781:1998;351-354.
25. Jacques D., Tong Y., Shen S.H., Quirion R. Discrete distribution of the neuropeptide Y Y5 receptor gene in the human brain: an in situ hybridization study. Brain Res. molec. Brain Res. 61:1998;100-107.
26. Klapstein G.J., Colmers W.F. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J. Neurophysiol. 78:1997;1651-1661.
27. Klapstein G.J., Colmers W.F. On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus. 3:1993;103-111.
28. Kofler N., Kirchmair E., Schwarzer C., Sperk G. Altered expression of NPY-Y1 receptors in kainic acid induced epilepsy in rats. Neurosci. Lett. 230:1997;129-132.
29. Kopp J., Nanobashvili A., Kokaia Z., Lindvall O., Hokfelt T. Differential regulation of mRNAs for neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis. Brain Res. molec. Brain Res. 72:1999;17-29.
30. Larhammar D., Blomqvist A.G., Yee F., Jazin E., Yoo H., Wahlested C. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J. biol. Chem. 267:1992;10,935-10,938.
31. Lundell I., Blomqvist A.G., Berglund M.M., Schober D.A., Johnson D., Statnick M.A., Gadski R.A., Gehlert D.R., Larhammar D. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J. biol. Chem. 270:1995;29,123-29,128.
32. Lundell I., Statnick M.A., Johnson D., Schober D.A., Starback P., Gehlert D.R., Larhammar D. The cloned rat pancreatic polypeptide receptor exhibits profound differences to the orthologous receptor. Proc. natn. Acad. Sci. U.S.A. 93:1996;5111-5115.
33. Marsh D.J., Baraban S.C., Hollopeter G., Palmiter R.D. Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc. natn. Acad. Sci. U.S.A. 96:1999;13,518-13,523.
34. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T. XVI International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50:1998;143-150.
35. Parker R.M., Herzog H. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 11:1999;1431-1448.
36. 2+ entry. J. Neurosci. 17:1997;8169-8177.
37. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroenceph. clin. Neurophysiol. 32:1972;281-294.
38. Redrobe J.P., Dumont Y., St-Pierre J.-A., Quirion R. Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition. Brain Res. 848:1999;153-166.
39. Rizzi M., Monno A., Samanin R., Sperk G., Vezzani A. Electrical kindling of the hippocampus is associated with functional activation of neuropeptide Y-containing neurons. Eur. J. Neurosci. 5:1993;1534-1538.
40. Rose P.M., Fernandes P., Lynch J.S., Frazier S.T., Fisher S.M., Kodukula K., Kienzle B., Seethala R. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J. biol. Chem. 270:1995;22,661-22,664.
41. Rudolf K., Eberlein W., Engel W., Wieland H.A., Willim K.D., Entzeroth M., Wienen W., Beck-Sickinger A.G., Doods H.N. The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur. J. Pharmacol. 271:1994;R11-13.
42. Schwarzer C., Kofler N., Sperk G. Up-regulation of neuropeptide Y-Y2 receptors in an animal model of temporal lobe epilepsy. Molec. Pharmacol. 53:1998;6-13.
43. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc. natn. Acad. Sci. U.S.A. 79:1982;5485-5489.
44. Vezzani A., Sperk G., Colmers W.F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci. 22:1999;25-30.
45. Wahlestedt C., Reis D.J. Neuropeptide Y-related peptides and their receptors (are the receptors potential therapeutic drug targets?). Ann. Rev. Pharmacol. Toxicol. 33:1993;309-352.
46. Weinberg D.H., Sirinathsinghji D.J., Tan C.P., Shiao L.L., Morin N., Rigby M.R., Heavens R.H., Rapoport D.R., Bayne M.L., Cascieri M.A., Strader C.D., Linemeyer D.L., MacNeil D.J. Cloning and expression of a novel neuropeptide Y receptor. J. biol. Chem. 271:1996;16,435-16,438.
47. Woldbye D.P. Antiepileptic effects of NPY on pentylenetetrazole seizures. Regul. Pept. 76:1998;279-282.
48. Woldbye D.P., Larsen P.J., Mikkelsen J.D., Klemp K., Madsen T.M., Bolwig T.G. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nat. Med. 3:1997;761-764.
49. Woldbye D.P., Madsen T.M., Larsen P.J., Mikkelsen J.D., Bolwig T.G. Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res. 737:1996;162-168.